<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>FQHC Intel — Federal</title>
    <link>https://www.fqhctalent.com</link>
    <description>Region-scoped intelligence: Federal FQHC policy, funding, workforce, and strategy.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 27 Jul 2026 19:59:52 GMT</lastBuildDate>
    <atom:link href="https://www.fqhctalent.com/intel-feed/federal" rel="self" type="application/rss+xml" />
    <item>
      <title>D.C. Circuit: drug makers can&apos;t force a 340B rebate model without HHS approval — the Secretary, not manufacturers, controls the program</title>
      <link>https://www.fqhctalent.com/intel/dc-circuit-340b-rebate-model-hhs-approval-july-2026</link>
      <description>On July 21, 2026 the U.S. Court of Appeals for the D.C. Circuit upheld a lower court and ruled that Section 340B does not permit manufacturers (Novartis and Johnson &amp; Johnson) to unilaterally replace up-front 340B discounts with a post-purchase rebate model unless the HHS Secretary approves it — holding, in effect, that the statute puts the Secretary and not the manufacturers in control of the program. The decision preserves the up-front-discount structure that community health centers and their contract pharmacies depend on, while leaving open whether HHS could authorize a rebate model in the future. It is a defensive win, not a permanent fix: other manufacturer proposals and HHS&apos;s own rebate-pilot review remain live.

Primary source: American Hospital Association (reporting the D.C. Circuit ruling) — https://www.aha.org/news/headline/2026-07-21-court-rules-companies-may-not-impose-340b-rebate-model-without-hhs-approval</description>
      <pubDate>Tue, 21 Jul 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/dc-circuit-340b-rebate-model-hhs-approval-july-2026</guid>
      <category>funding</category>
      <source url="https://www.aha.org/news/headline/2026-07-21-court-rules-companies-may-not-impose-340b-rebate-model-without-hhs-approval">American Hospital Association (reporting the D.C. Circuit ruling)</source>
    </item>
    <item>
      <title>CMS and CDC reopen the CLIA regulations with a request for information — comments close September 14</title>
      <link>https://www.fqhctalent.com/intel/cms-cdc-clia-regulations-rfi-july-2026</link>
      <description>CMS and CDC published a Request for Information on the Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations in the Federal Register on July 16, 2026 (CMS-3485-NC, docket CMS-2026-2345). In the document&apos;s own words, it &apos;seeks input from the public regarding various topics related to the CLIA regulations, including: breath testing; laboratory processes and procedures; emergency preparedness, biosafety and biosecurity, and cybersecurity; and specialty testing areas.&apos; Comments close September 14, 2026. BE PRECISE ABOUT WHY THIS IS HERE: the RFI does not mention FQHCs, RHCs, community health centers, certificates of waiver, or physician office laboratories anywhere in its text — that was checked term by term. The health-center relevance is structural, not asserted by the document: essentially every health center holds a CLIA certificate (most commonly a Certificate of Waiver or PPM) for in-clinic testing, so any rulemaking that follows would reach them the way it reaches every other CLIA-certified site. This is the first substantive regulatory reopening of CLIA since the 1992 implementing rules, which makes the comment window unusually consequential for small-volume testing sites that rarely get represented in lab policy. Do not read any FQHC-specific certification or billing change into this document — there is none yet, only a question-asking stage.

Primary source: CMS / CDC — Federal Register — https://www.federalregister.gov/documents/2026/07/16/2026-14358/request-for-information-clinical-laboratory-improvement-amendments-of-1988-clia-regulations</description>
      <pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/cms-cdc-clia-regulations-rfi-july-2026</guid>
      <category>compliance</category>
      <source url="https://www.federalregister.gov/documents/2026/07/16/2026-14358/request-for-information-clinical-laboratory-improvement-amendments-of-1988-clia-regulations">CMS / CDC — Federal Register</source>
    </item>
    <item>
      <title>CY2027 Physician Fee Schedule Proposed Rule Lands — CMS Proposes the FQHC PPS Base Rate Rise to $212.91 (+2.5%), Comments Close September 14</title>
      <link>https://www.fqhctalent.com/intel/cy2027-pfs-proposed-rule-fqhc-pps-base-rate-212-july-2026</link>
      <description>CMS published the CY2027 Physician Fee Schedule proposed rule (CMS-1848-P, FR doc 2026-14327) in today&apos;s Federal Register — 91 FR 43842–44557, comments close September 14, 2026. This resolves the watch item carried in this file&apos;s header for the last several cycles. The headline FQHC number, verbatim from the rule at 91 FR 43959: &quot;Multiplying the CY 2026 FQHC PPS base rate amount of $207.72 by the proposed CY 2027 FQHC market basket update of 2.5 percent ($207.72 x 1.025) results in a proposed CY 2027 FQHC PPS base rate amount of $212.91.&quot; Treat $212.91 as PROVISIONAL, not locked: CMS states it will refresh the market basket and productivity adjustment at the final rule using historical data through Q2 2026, so the final figure will move. The rule also proposes conforming regulatory text (§§405.2463(b)(3), 405.2469(d)) for CAA-2026 §6209(d), which delays the RHC/FQHC in-person visit requirement for mental-health telehealth to an extended date of January 1, 2028 — note the underlying statute (Pub. L. 119-75, Feb 3 2026) is already tracked; only the regulatory codification is new here, so do not re-report the statute as news. Two honesty notes. (1) The proposed DSMT/MNT stand-alone-visit change is an RHC proposal that aligns RHCs UP to existing FQHC treatment — FQHC payment is unchanged, and it should not be framed as an FQHC win; CMS adds that it does &quot;not expect in future rulemaking to propose additional preventive services beyond which are currently paid for in FQHCs,&quot; i.e. it considers the FQHC preventive menu complete. (2) The ACCESS Model co-management G-codes G0676/G0677/G0678 appear ZERO times in all 716 pages, as does &quot;ACCESS Model&quot; — the rule that would naturally have settled FQHC billing eligibility is silent, so our UNCONFIRMED framing stands and must not be upgraded.

Primary source: Federal Register / CMS — https://www.federalregister.gov/documents/2026/07/16/2026-14327/medicare-and-medicaid-programs-cy-2027-payment-policies-under-the-physician-fee-schedule-and-other</description>
      <pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/cy2027-pfs-proposed-rule-fqhc-pps-base-rate-212-july-2026</guid>
      <category>legislation</category>
      <source url="https://www.federalregister.gov/documents/2026/07/16/2026-14327/medicare-and-medicaid-programs-cy-2027-payment-policies-under-the-physician-fee-schedule-and-other">Federal Register / CMS</source>
    </item>
    <item>
      <title>National Study Finds About One-Third of Eligible FQHCs Lack Onsite Prenatal Care</title>
      <link>https://www.fqhctalent.com/intel/fqhc-onsite-prenatal-care-gap-annals-study-july-2026</link>
      <description>An observational study published July 14 in Annals of Internal Medicine analyzed 1,326 FQHCs operating in 2024 after excluding U.S. territories and centers serving fewer than 100 adult female patients. About two-thirds provided onsite prenatal care and about one-third did not. Onsite care was more common among urban centers and centers serving higher proportions of Black, Hispanic, Medicaid, and limited-English-proficiency patients. The researchers also found that maternity-care deserts often had no FQHC or had an FQHC without onsite prenatal services.

Primary source: Annals of Internal Medicine — https://www.acpjournals.org/doi/10.7326/ANNALS-26-00381</description>
      <pubDate>Tue, 14 Jul 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/fqhc-onsite-prenatal-care-gap-annals-study-july-2026</guid>
      <category>workforce</category>
      <source url="https://www.acpjournals.org/doi/10.7326/ANNALS-26-00381">Annals of Internal Medicine</source>
    </item>
    <item>
      <title>Court stay puts MSN, DNP and PA programs on an interim &apos;professional degree&apos; list; July 10 update clarifies nursing scope</title>
      <link>https://www.fqhctalent.com/intel/ed-professional-degree-list-nursing-pa-loan-limits-july-2026</link>
      <description>The Department of Education&apos;s RISE final rule narrowed the definition of &apos;professional degree.&apos; On June 24, 2026, the U.S. District Court for the District of Columbia (consolidated Nos. 26-1780 and 26-1941) preliminarily stayed part of that definition. ED&apos;s June 29 interim list for the duration of the stay expressly includes Registered Nursing (MSN), Nursing Practice (DNP), and Physician Associate/Assistant (MSPA; PA) programs. The July 10 update clarified that the MSN and DNP entries include programs within the same four-digit CIP code that award the same credential and added the Ph.D. designation for Clinical Psychology; PA was already on the June 29 list. Institutions may use the higher professional-student loan limits for qualifying programs during the stay, although institutions may set lower program-level limits. The health-center relevance is indirect: these programs feed nursing, advanced-practice, PA, and behavioral-health roles used by FQHCs. The ED announcement does not mention FQHCs, and this is a temporary litigation posture, not a final outcome; Grad PLUS remains eliminated and the interim designations may change.

Primary source: U.S. Department of Education — Federal Student Aid — https://fsapartners.ed.gov/knowledge-center/library/electronic-announcements/2026-06-29/update-list-professional-degree-programs-due-court-order-updated-july-10-2026</description>
      <pubDate>Fri, 10 Jul 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/ed-professional-degree-list-nursing-pa-loan-limits-july-2026</guid>
      <category>workforce</category>
      <source url="https://fsapartners.ed.gov/knowledge-center/library/electronic-announcements/2026-06-29/update-list-professional-degree-programs-due-court-order-updated-july-10-2026">U.S. Department of Education — Federal Student Aid</source>
    </item>
    <item>
      <title>Eli Lilly&apos;s 340B Termination Turns Into Litigation and Congressional Pushback — Tampa General Sues in Federal Court, 72 House Members Demand HHS Act</title>
      <link>https://www.fqhctalent.com/intel/lilly-340b-termination-tampa-general-lawsuit-house-letter-july-2026</link>
      <description>Eli Lilly&apos;s June 1 five-day ultimatum escalated on June 18, 2026, when the manufacturer cut off 340B pricing for covered entities that refused to share in-house pharmacy claims data — Lilly directed wholesaler McKesson to end Tampa General Hospital&apos;s discounts after it missed the deadline, per the hospital&apos;s complaint. Tampa General sued Lilly on July 2 in the U.S. District Court for the Middle District of Florida, alleging the cutoff raised its average costs for Lilly medications 25-50% — losses the complaint pegs at roughly $24.7 million a year, including a 35.9% jump on Mounjaro. Separately, 72 bipartisan U.S. House members — led by Reps. Doris Matsui (D-CA) and Jack Bergman (R-MI) — signed an early-July letter to HHS Secretary Kennedy and HRSA Administrator Engels urging use of &apos;any enforcement mechanisms available&apos; against Lilly&apos;s move and restoration of 340B pricing. Coverage so far documents hospitals as the entities cut off; no health-center termination has been confirmed, but FQHCs dispensing Lilly products face the same claims-data condition documented in the June 1 ultimatum item and should confirm their data-sharing posture now.

Primary source: WUSF (Health News Florida); Essential Hospitals; BioPharma Dive — https://www.wusf.org/health-news-florida/2026-07-10/tampa-general-hospital-sues-eli-lilly-over-reporting-demands-for-340b-discounts</description>
      <pubDate>Fri, 10 Jul 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/lilly-340b-termination-tampa-general-lawsuit-house-letter-july-2026</guid>
      <category>compliance</category>
      <source url="https://www.wusf.org/health-news-florida/2026-07-10/tampa-general-hospital-sues-eli-lilly-over-reporting-demands-for-340b-discounts">WUSF (Health News Florida); Essential Hospitals; BioPharma Dive</source>
    </item>
    <item>
      <title>OIG declines to sanction an FQHC&apos;s produce-box and voucher program — a favorable outcome, but one that legally protects only the health center that asked</title>
      <link>https://www.fqhctalent.com/intel/oig-advisory-opinion-26-16-fqhc-produce-boxes-july-2026</link>
      <description>HHS-OIG issued Advisory Opinion 26-16 on July 9, 2026 (posted July 14) to a requestor it describes in its own words as &apos;designated as a federally qualified health center, consistent with Section 330 of the Public Health Service Act.&apos; The arrangement: a six-month food-as-medicine program for 50 financially needy patients with diabetes or hypertension, half receiving weekly $30 produce boxes delivered to their homes and half receiving weekly $20 vouchers redeemable for healthy food at grocery chains and farmers markets, wrapped in dietician assessments, physician oversight and lab testing. READ THE HOLDING CAREFULLY — it is narrower than &apos;approved.&apos; OIG found the arrangement WOULD generate prohibited remuneration under the anti-kickback statute if the requisite intent were present, and that it DOES generate prohibited remuneration under the Beneficiary Inducements CMP; it then exercised enforcement discretion and declined to impose administrative sanctions, citing safeguards (voucher-redemption tracking, retailer MOUs limiting eligible items, free provision of produce, billing under the health center&apos;s sliding fee discount policy per HRSA Compliance Manual Ch. 9, no laboratory remuneration, grant funding). CRITICAL LIMITATION, in the opinion&apos;s own words: &apos;This advisory opinion is issued only to Requestor. This advisory opinion has no application to, and cannot be relied upon by, any other person.&apos; It also expressly reserves any opinion on Stark or the False Claims Act. So this is a genuinely encouraging signal about how OIG views structured food-as-medicine programs — and it is NOT legal cover for another health center to launch one. Treat it as a template for the safeguards to build in and a reason to seek your own counsel, not as permission.

Primary source: HHS Office of Inspector General — https://oig.hhs.gov/compliance/advisory-opinions/26-16/</description>
      <pubDate>Thu, 09 Jul 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/oig-advisory-opinion-26-16-fqhc-produce-boxes-july-2026</guid>
      <category>compliance</category>
      <source url="https://oig.hhs.gov/compliance/advisory-opinions/26-16/">HHS Office of Inspector General</source>
    </item>
    <item>
      <title>CMS Keeps the 35% Essential Community Provider Standard in the 2027 Marketplace Final Rule — a Rulemaking Win NACHC Fought For</title>
      <link>https://www.fqhctalent.com/intel/cms-2027-nbpp-final-rule-ecp-35pct-preserved-2026</link>
      <description>In the 2027 Notice of Benefit and Payment Parameters final rule (published May 15, 2026; effective July 20), HHS declined to finalize its proposal to cut the Essential Community Provider contracting standard from 35% to 20% — qualified health plans must still contract with at least 35% of available ECPs, a category that includes FQHCs, in each service area. NACHC had formally opposed the cut in comments, calling it &apos;premature&apos; absent any assessment of how the 35% threshold affects access for the low-income patients health centers serve, and claimed the outcome as a rulemaking win in a July 8 post. The final rule also prohibits issuers from including routine non-pediatric (adult) dental services as an essential health benefit and tightens enforcement when premium-tax-credit recipients fail to file and reconcile. For health centers, the standing 35% floor preserves in-network eligibility with Marketplace plans and the commercially insured volume that supports their payer mix.

Primary source: HHS/CMS (2027 NBPP final rule); Essential Hospitals; NACHC — https://essentialhospitals.org/hhs-publishes-2027-marketplace-final-rule/</description>
      <pubDate>Wed, 08 Jul 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/cms-2027-nbpp-final-rule-ecp-35pct-preserved-2026</guid>
      <category>lobbying</category>
      <source url="https://essentialhospitals.org/hhs-publishes-2027-marketplace-final-rule/">HHS/CMS (2027 NBPP final rule); Essential Hospitals; NACHC</source>
    </item>
    <item>
      <title>Section 1557 Language Access Annual Notice Year 1 Anniversary — July 5, 2026 Compliance Window</title>
      <link>https://www.fqhctalent.com/intel/section-1557-language-access-anniversary-july-2026</link>
      <description>HHS Section 1557 Annual Notice of Availability (free language assistance services in English + 15 most common LEP languages in the state) has been in effect since July 5, 2025. Year 1 compliance review window approaching July 5, 2026. CA&apos;s 15 LEP languages include Spanish, Chinese, Vietnamese, Tagalog, Korean, Armenian, Russian, Persian, Arabic, Punjabi, Khmer, Hmong, Hindi, Japanese, Mon-Khmer. All FQHCs taking Medicare/Medi-Cal must have posted, distributed, and translated the Notice — pairs with the May 11, 2026 WCAG 2.1AA deadline as a compounding civil rights compliance window for FQHCs. Two HHS OCR rules with overlapping enforcement risk in the same 8-week window.

Primary source: HHS OCR — https://www.hhs.gov/sites/default/files/ocr-dcl-section-1557-language-access.pdf</description>
      <pubDate>Sun, 05 Jul 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/section-1557-language-access-anniversary-july-2026</guid>
      <category>compliance</category>
      <source url="https://www.hhs.gov/sites/default/files/ocr-dcl-section-1557-language-access.pdf">HHS OCR</source>
    </item>
    <item>
      <title>DOJ Stands Up National Fraud Enforcement Division — Healthcare Billing Now Has a Dedicated Litigating Division</title>
      <link>https://www.fqhctalent.com/intel/doj-nfed-national-fraud-enforcement-division-april-7-2026</link>
      <description>Acting U.S. Attorney General Todd Blanche announced (April 7, 2026) the National Fraud Enforcement Division (NFED) — a stand-alone DOJ litigating division consolidating the Tax Section, Health Care Fraud Unit, and Market/Government/Consumer Fraud Unit under one assistant attorney general. Each U.S. Attorney&apos;s office must designate a prosecutor to NFED within 21 days. A new National Fraud Detection Center generates investigative leads from federal financial data — meaning billing anomalies can trigger investigation independent of whistleblower complaints. Combined with FY2025 record $6.8B FCA recoveries (84% from healthcare = $5.7B), 2026 enforcement risk is structurally elevated for FQHCs. PPS billing, incident-to claims, telehealth FQHC distant-site billing, 340B claim integrity, and Anti-Kickback/Stark exposure are all in scope. Strategic action items for CFOs and compliance officers in May–June: (1) refresh PPS encounter documentation review, (2) audit incident-to billing for NP/PA visits, (3) reconfirm 340B contract pharmacy patient-definition compliance, (4) tighten BAA inventory and breach-response runbook (pairs with the OCR ransomware sweep enforcement posture).

Primary source: Holland &amp; Knight — https://www.hklaw.com/en/insights/publications/2026/04/doj-establishes-national-fraud-enforcement-division</description>
      <pubDate>Fri, 03 Jul 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/doj-nfed-national-fraud-enforcement-division-april-7-2026</guid>
      <category>compliance</category>
      <source url="https://www.hklaw.com/en/insights/publications/2026/04/doj-establishes-national-fraud-enforcement-division">Holland &amp; Knight</source>
    </item>
    <item>
      <title>8th Circuit Rejects Novartis&apos;s Bid to Block Missouri&apos;s 340B Contract-Pharmacy Law — Another State Shield Survives a Manufacturer Challenge</title>
      <link>https://www.fqhctalent.com/intel/8th-circuit-missouri-sb751-340b-novartis-july-2026</link>
      <description>On July 1, 2026, the 8th U.S. Circuit Court of Appeals (Novartis Pharmaceuticals Corp. v. Hanaway, No. 25-1619) affirmed the district court&apos;s denial of Novartis&apos;s preliminary-injunction bid against Missouri&apos;s S.B. 751, which requires manufacturers to deliver 340B drugs to all contract pharmacies serving Missouri covered entities. Per the Missouri Hospital Association, the court found Novartis unlikely to prevail on the merits — any extraterritorial effect of the statute was &apos;negligible and nondiscriminatory toward out-of-state entities&apos; — and rejected Novartis&apos;s attempt to revisit its position on federal preemption; the case now returns to the district court for merits proceedings. The Missouri Primary Care Association (the state&apos;s FQHC association) intervened alongside MHA to defend the law. The ruling adds another upheld state 340B contract-pharmacy shield to the circuit-by-circuit map FQHC pharmacy directors are tracking, weeks after Washington&apos;s law survived a separate challenge in June.

Primary source: Missouri Hospital Association; Powers Law (intervenors&apos; counsel) — https://www.mohospitals.org/newsroom/eighth-circuit-rejects-novartis-appeal-in-340b-litigation</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/8th-circuit-missouri-sb751-340b-novartis-july-2026</guid>
      <category>legislation</category>
      <source url="https://www.mohospitals.org/newsroom/eighth-circuit-rejects-novartis-appeal-in-340b-litigation">Missouri Hospital Association; Powers Law (intervenors&apos; counsel)</source>
    </item>
    <item>
      <title>AHA Files En Banc Review Petition After 4th Circuit Blocks WV 340B Contract Pharmacy Law — Decision Expected Mid-May</title>
      <link>https://www.fqhctalent.com/intel/aha-en-banc-petition-4th-circuit-340b-wv-april-17-2026</link>
      <description>American Hospital Association filed en banc review petition April 17 after 4th Circuit panel blocked West Virginia&apos;s S.B. 325 (which forced manufacturers to ship 340B drugs to contract pharmacies). Combined with the 4th Circuit&apos;s April 14 vacatur of Maryland&apos;s similar law, drugmakers won two consecutive 4th Circuit rulings. AHA argues panel decision conflicts with 5th and 8th Circuit rulings, citing critical importance of preserving state-level 340B protections. Decision window typically 30 days. Outcome shapes whether other 4th Circuit states (NC, SC, VA) can pass 340B contract pharmacy access laws — and indirectly affects circuit-split posture for likely Supreme Court review.

Primary source: AHA — https://www.aha.org/news/headline/2026-04-17-aha-urges-en-banc-review-4th-circuits-west-virginia-340b-contract-pharmacy-law-decision</description>
      <pubDate>Tue, 30 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/aha-en-banc-petition-4th-circuit-340b-wv-april-17-2026</guid>
      <category>legislation</category>
      <source url="https://www.aha.org/news/headline/2026-04-17-aha-urges-en-banc-review-4th-circuits-west-virginia-340b-contract-pharmacy-law-decision">AHA</source>
    </item>
    <item>
      <title>NACHC: Integrated Behavioral Health Is Working in CHCs, but Payment Reform Has to Catch Up</title>
      <link>https://www.fqhctalent.com/intel/nachc-integrated-behavioral-health-structural-reform-june-2026</link>
      <description>NACHC&apos;s June 29 national brief argues that community health centers have proven integrated primary care and behavioral health can work, but current payment structures still underpay same-day behavioral health access, care coordination, telehealth infrastructure, and risk adjustment for complex patients. The brief cites 34 million annual CHC patients, nearly 3.3 million behavioral-health patients in 2024, telehealth adoption rising from 42% to 98% between 2019 and 2024, and Medicaid supplying 44% of total CHC revenue — making stable Medicaid coverage and VBC models central to sustaining integrated care.

Primary source: NACHC — https://www.nachc.org/community-health-centers-show-integrated-care-can-work-structural-reform-must-follow/</description>
      <pubDate>Mon, 29 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/nachc-integrated-behavioral-health-structural-reform-june-2026</guid>
      <category>funding</category>
      <source url="https://www.nachc.org/community-health-centers-show-integrated-care-can-work-structural-reform-must-follow/">NACHC</source>
    </item>
    <item>
      <title>NACHC Launches &apos;NACHC Cares&apos; Employee-Benefits Program for the 330,000-Person Community Health Center Workforce</title>
      <link>https://www.fqhctalent.com/intel/nachc-clearpoint-nachc-cares-benefits-june-2026</link>
      <description>On June 26, NACHC and ClearPoint Health announced &apos;NACHC Cares,&apos; a strategic partnership giving the nation&apos;s ~330,000 community health center employees access to customizable employer-sponsored health plans, clinical risk management, and benefits-concierge services across 1,512 health centers. NACHC framed it as a workforce-sustainability and retention tool at a moment of acute financial pressure on health centers.

Primary source: NACHC — https://www.nachc.org/nachc-partners-with-clearpoint-health-to-expand-innovative-health-insurance-solutions-to-community-health-centers/</description>
      <pubDate>Fri, 26 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/nachc-clearpoint-nachc-cares-benefits-june-2026</guid>
      <category>workforce</category>
      <source url="https://www.nachc.org/nachc-partners-with-clearpoint-health-to-expand-innovative-health-insurance-solutions-to-community-health-centers/">NACHC</source>
    </item>
    <item>
      <title>Senate HELP Chair Cassidy Releases Comprehensive 340B Reform Discussion Draft — the Federal Rewrite Vehicle Arrives</title>
      <link>https://www.fqhctalent.com/intel/cassidy-340b-discussion-draft-june-2026</link>
      <description>Senate HELP Committee Chair Bill Cassidy (R-LA) released a legislative discussion draft of the &apos;340B Drug Pricing Integrity and Affordability for Patients Act&apos; on June 25, 2026 — the most comprehensive federal 340B rewrite vehicle to emerge this cycle. Key provisions per the committee release and STAT coverage: restrictions on hospital &apos;child sites&apos; (which would need to provide services beyond drug dispensing and be located in shortage areas) and a requirement that hospital covered entities adopt sliding fee scales — a discipline FQHCs already live under by statute. For health centers, the draft lands in a crowded field: the health-center-side &apos;340C&apos; proposal (a voluntary, transparent subset with contract-pharmacy protection and WAC reimbursement for Medicaid drugs) and the already-tracked bipartisan H.R. 7391 340B FQHC Protection Act remain the CHC counter-positions. Strategic read: most of Cassidy&apos;s draft targets hospital behavior, not health centers — but any comprehensive 340B rewrite that moves opens the whole program, contract-pharmacy rules included, while the December 31 CHC Fund cliff still has no legislative vehicle of its own. Status: discussion draft (not yet introduced); comment and stakeholder engagement expected over summer 2026.

Primary source: U.S. Senate HELP Committee — https://www.help.senate.gov/rep/newsroom/press/chairman-cassidy-unveils-landmark-discussion-draft-to-fix-340b-lower-health-costs-for-american-patients-and-families</description>
      <pubDate>Thu, 25 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/cassidy-340b-discussion-draft-june-2026</guid>
      <category>legislation</category>
      <source url="https://www.help.senate.gov/rep/newsroom/press/chairman-cassidy-unveils-landmark-discussion-draft-to-fix-340b-lower-health-costs-for-american-patients-and-families">U.S. Senate HELP Committee</source>
    </item>
    <item>
      <title>DOJ’s 2026 National Health Care Fraud Takedown charges 455 defendants in $6.5B of alleged fraud — community mental health among named targets</title>
      <link>https://www.fqhctalent.com/intel/doj-2026-national-health-care-fraud-takedown-june-2026</link>
      <description>On June 25, 2026 the U.S. Department of Justice, HHS-OIG, and partner agencies announced the 2026 National Health Care Fraud Takedown: criminal charges against 455 defendants (including about 90 licensed medical professionals) tied to more than $6.5 billion in alleged false claims, with over $182 million in cash, luxury vehicles, jewelry, and other assets seized. Community mental health and behavioral health services were explicitly named among targeted billing categories. No health center is named, but FQHCs that bill integrated behavioral health face heightened audit and documentation scrutiny; the takedown signals where Medicaid and Medicare program-integrity enforcement is concentrating in 2026.

Primary source: HHS Office of Inspector General / U.S. Department of Justice — https://oig.hhs.gov/fraud/enforcement/2026-national-health-care-fraud-takedown/</description>
      <pubDate>Thu, 25 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/doj-2026-national-health-care-fraud-takedown-june-2026</guid>
      <category>compliance</category>
      <source url="https://oig.hhs.gov/fraud/enforcement/2026-national-health-care-fraud-takedown/">HHS Office of Inspector General / U.S. Department of Justice</source>
    </item>
    <item>
      <title>HRSA Quietly Restarts the 340B Rebate Model Pilot — Revised Application Package in the Federal Register, Comments Due July 15</title>
      <link>https://www.fqhctalent.com/intel/hrsa-340b-rebate-pilot-2-revival-icr-june-2026</link>
      <description>Four months after a federal court vacated the first 340B Rebate Model Pilot (AHA v. Kennedy, February 2026), HRSA has taken the first formal step toward Rebate Pilot 2.0: an Information Collection Request for a revised &apos;340B Rebate Model Pilot Program Application, Implementation, and Evaluation&apos; published in the Federal Register June 15, 2026, with public comments due July 15, 2026. A June 22 correction notice revised the estimated responses to include 11 manufacturer Pilot Program Plan submissions — signaling HRSA anticipates MORE manufacturers in the revived pilot than the ~8-9 approved in the vacated first round. Guardrails from the February joint vacatur motion still bind: any new rebate program requires fresh public notice-and-comment and an effective date no earlier than 90 days after manufacturer-application approvals, sliding the earliest realistic go-live toward late 2026 or 2027. Strategic implication for FQHCs: a rebate model converts upfront 340B discounts into after-the-fact rebates — a working-capital hit covered entities (including NACHC) fought in round one. The July 15 comment window is the 13-day action item.

Primary source: HRSA / Federal Register — https://www.federalregister.gov/documents/2026/06/22/2026-12442/340b-rebate-model-pilot-program-application-implementation-and-evaluation-correction</description>
      <pubDate>Mon, 15 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/hrsa-340b-rebate-pilot-2-revival-icr-june-2026</guid>
      <category>funding</category>
      <source url="https://www.federalregister.gov/documents/2026/06/22/2026-12442/340b-rebate-model-pilot-program-application-implementation-and-evaluation-correction">HRSA / Federal Register</source>
    </item>
    <item>
      <title>CMS Issues State Medicaid Director Letter #26-003 — Chief Actuary Must Certify Section 1115 Demonstrations Won&apos;t Increase Federal Spending Starting Jan. 1, 2027</title>
      <link>https://www.fqhctalent.com/intel/cms-smdl-26-003-1115-budget-neutrality-chief-actuary-june-2026</link>
      <description>On June 11, 2026, CMS released State Medicaid Director Letter #26-003, giving states early notice of a new statutory requirement (Section 71118 of H.R. 1, the law also referred to as the Working Families Tax Cut Act) that the CMS Chief Actuary must certify that new, renewed, or amended Section 1115 Medicaid demonstrations approved on or after January 1, 2027 will not increase federal Medicaid spending. The letter replaces the historical &apos;without waiver&apos; expenditure-cap budget-neutrality model with a stricter no-increase standard and a more rigorous, individualized financial-impact analysis for each 1115-only activity. CMS followed on July 7 with a bulletin formally rescinding its 2015 &apos;fast-track&apos; review process for certain 1115 extensions, citing the new actuarial requirement. For California, this narrows the room available when CalAIM&apos;s Section 1115 waiver — which funds Enhanced Care Management and Community Supports that many FQHCs bill through managed-care plans — comes up for renewal ahead of its December 31, 2026 expiration; states with 2027 renewals in the pipeline should expect added actuarial documentation burden.

Primary source: CMS (SMDL #26-003), via Sellers Dorsey / Health Management Associates — https://www.sellersdorsey.com/insights/cms-special-coverage/summary-of-cms-state-medicaid-director-letter-smdl-26-003-budget-neutrality-and-certification-by-the-chief-actuary-for-section-1115-medicaid-demonstration-projects/</description>
      <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/cms-smdl-26-003-1115-budget-neutrality-chief-actuary-june-2026</guid>
      <category>funding</category>
      <source url="https://www.sellersdorsey.com/insights/cms-special-coverage/summary-of-cms-state-medicaid-director-letter-smdl-26-003-budget-neutrality-and-certification-by-the-chief-actuary-for-section-1115-medicaid-demonstration-projects/">CMS (SMDL #26-003), via Sellers Dorsey / Health Management Associates</source>
    </item>
    <item>
      <title>The work-requirement map, 6 months out: 4 states going early, Nebraska&apos;s freeze is the preview, and Georgia&apos;s 5% enrollment rate is the warning</title>
      <link>https://www.fqhctalent.com/intel/medicaid-work-req-state-implementation-map-june-2026</link>
      <description>With CMS-2454-IFC taking effect July 31 (the Federal Register DATES section publishes an effective date only, no comment deadline — corrected 2026-07-22) and full implementation due January 1, 2027, the state map has taken shape. Four states are going early: Nebraska (enforcing since May 1), Montana (July 1), Arkansas (soft launch July 1), and Iowa (December 1, with no high-unemployment hardship exception) — plus Idaho (Dec 31 statutory deadline with the nation&apos;s longest 3-month lookback) and Kentucky (HB 2&apos;s pre-enrollment proof requirement, enacted over the governor&apos;s veto). Nebraska&apos;s &apos;soft start&apos; is producing the first hard national data: ZERO new Medicaid enrollees in May versus a typical ~15/month at the state&apos;s health centers (a pure chilling effect — termination checks don&apos;t even begin until July 31), with 20,000-28,000 of ~70,000 expansion enrollees flagged for documentation. Georgia&apos;s Pathways — the only mature work-requirement program — has enrolled ~16,183 people in three years, about 5% of its potential population. Two mitigations worth copying: Utah exempted homeless individuals (FQHC-designed, NACHC-endorsed), and Oregon exempted FQHC visits from new cost-sharing. The operational takeaway repeats Nebraska&apos;s lesson everywhere: the chilling effect arrives before the disenrollments do, and clinics&apos; navigation capacity is the rail it all runs on.

Primary source: Georgetown CCF / CBPP / KFF — https://ccf.georgetown.edu/feature/tracking-implementation-of-h-r-1-medicaid-work-reporting-requirements/</description>
      <pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/medicaid-work-req-state-implementation-map-june-2026</guid>
      <category>legislation</category>
      <source url="https://ccf.georgetown.edu/feature/tracking-implementation-of-h-r-1-medicaid-work-reporting-requirements/">Georgetown CCF / CBPP / KFF</source>
    </item>
    <item>
      <title>The $50B rural health fund is now real money with real deadlines: Florida June 17, Alaska June 22, Indiana July 1, Tennessee July 6-20 — and FQHCs must compete for every dollar</title>
      <link>https://www.fqhctalent.com/intel/rhtp-50b-sub-grant-windows-fqhc-deadline-calendar-june-2026</link>
      <description>Six months after CMS announced all 50 states&apos; Rural Health Transformation Program Year-1 awards (Dec 29, 2025; $147M for New Jersey to $281M for Texas), the state sub-grant windows FQHCs can actually apply to are opening in a cluster: Florida&apos;s RFA closes June 17; Alaska&apos;s $272M application portal closes June 22; Indiana&apos;s $120M GROW coalition applications are due July 1; Tennessee&apos;s CARE Grant RFP runs July 6-20; West Virginia is posting $60M+ in rolling two-week windows. The fine print that decides who benefits: CMS caps rural-hospital/provider allocations, the money is one-time against permanent Medicaid cuts (Georgetown CCF calls the mismatch structural), at least 32 states wrote CHW workforce development into their plans (NASHP), Tennessee tied full funding to eliminating Certificate of Need by January 2027, and several states route funds through regional coalitions FQHCs must join rather than apply to alone. CMS reviews state progress beginning late summer; Year-2 amounts land in October. For rural health centers this is the largest additive federal money of 2026 — but it must be chased state by state, deadline by deadline.

Primary source: CMS / KFF / NASHP — https://www.kff.org/state-health-policy-data/first-year-rural-health-fund-awards-range-from-less-than-100-per-rural-resident-in-ten-states-to-more-than-500-in-eight/</description>
      <pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/rhtp-50b-sub-grant-windows-fqhc-deadline-calendar-june-2026</guid>
      <category>funding</category>
      <source url="https://www.kff.org/state-health-policy-data/first-year-rural-health-fund-awards-range-from-less-than-100-per-rural-resident-in-ten-states-to-more-than-500-in-eight/">CMS / KFF / NASHP</source>
    </item>
    <item>
      <title>The first post-H.R. 1 budget season splits the states: New York invests $80M in FQHCs while Colorado cuts rates 2% and New Jersey stares into a $3.6B/yr hole</title>
      <link>https://www.fqhctalent.com/intel/post-hr1-state-budget-divergence-backfillers-vs-cutters-2026</link>
      <description>With ~46 states starting FY2027 on July 1, the first budgets written entirely after H.R. 1 sort the country into camps. BACKFILLERS: New York ($1.5B in new Medicaid funding including $80M specifically for FQHC rates — the largest named FQHC investment of the cycle — plus a permanent provider tax), Connecticut ($5M routed directly to FQHCs from its Federal Cuts Response Fund), New Mexico ($40M for immigrant coverage plus an insurer surtax), and Minnesota ($205M to stabilize HCMC plus a $500M hospital uncompensated-care reserve). CUTTERS: Colorado (2% Medicaid provider rate cut effective July 1, with 65% of its health centers already at negative margins), Florida (special session weighing 3% hospital cuts), and structurally, New Jersey ($3.6B/yr permanent federal loss as its provider-tax mechanism phases down — the inverse of New York&apos;s). California sits unresolved past its June 15 deadline with the MCO tax in the balance. The divergence is the strategy lesson: the same federal law produces opposite state responses depending on whether a provider-tax mechanism survives — which is exactly what California is fighting about this week.

Primary source: Nixon Peabody / NJ Monitor / Colorado Sun / Georgetown CCF — https://www.nixonpeabody.com/insights/alerts/2026/06/04/select-health-related-provisions-in-new-york-fy-2026-2027-budget-bill</description>
      <pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/post-hr1-state-budget-divergence-backfillers-vs-cutters-2026</guid>
      <category>funding</category>
      <source url="https://www.nixonpeabody.com/insights/alerts/2026/06/04/select-health-related-provisions-in-new-york-fy-2026-2027-budget-bill">Nixon Peabody / NJ Monitor / Colorado Sun / Georgetown CCF</source>
    </item>
    <item>
      <title>The state immigrant-coverage rollback is now a national wave: Minnesota and Illinois ended programs, Washington froze, DC is phasing out, Colorado capped — and California&apos;s freeze fits the pattern</title>
      <link>https://www.fqhctalent.com/intel/state-immigrant-coverage-rollback-wave-2026</link>
      <description>What looked like isolated state decisions is now a coherent national retreat from state-funded immigrant health coverage, driven by H.R. 1 fiscal pressure and the threat of FMAP penalties for states covering barred populations. The inventory: Minnesota ended MinnesotaCare for undocumented adults January 1, 2026 (~57,000 people); Illinois ended HBIA (ages 42-64, ~30,000) in July 2025 and capped its seniors program; Washington&apos;s Apple Health Expansion hit its 13,000 cap and froze in December 2025; DC blocks Healthcare Alliance re-enrollment for adults 26+ and eliminates eligibility for 21+ by FY2028 (~26,000 covered, ~$12.4M/yr FQHC revenue); Colorado capped Cover All Coloradans at 25,000 children and slashed OmniSalud from ~12,000 to ~6,700 subsidized adults; and California froze new Medi-Cal enrollment for undocumented adults in January 2026 with the dental benefit ending July 1. Oregon&apos;s Healthier Oregon (100,000+ covered) survives but faces a ~$400M/yr federal penalty risk. Only a handful of states — MA, CT, RI, NM — are holding. For health centers the pattern is the point: these patients don&apos;t disappear, they reappear as self-pay sliding-fee visits, and the centers with the largest immigrant panels take the revenue hit in proportion to their mission.

Primary source: KFF / Stateline — https://www.kff.org/racial-equity-and-health-policy/recent-state-actions-impacting-immigrants-access-to-state-funded-health-coverage-and-other-public-programs/</description>
      <pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/state-immigrant-coverage-rollback-wave-2026</guid>
      <category>undocumented-access</category>
      <source url="https://www.kff.org/racial-equity-and-health-policy/recent-state-actions-impacting-immigrants-access-to-state-funded-health-coverage-and-other-public-programs/">KFF / Stateline</source>
    </item>
    <item>
      <title>MACPAC&apos;s June report hands FQHCs two federal hooks: a work-requirement monitoring mandate and a human-review requirement for AI prior-auth denials</title>
      <link>https://www.fqhctalent.com/intel/macpac-june-2026-report-work-req-monitoring-ai-prior-auth</link>
      <description>MACPAC — Congress&apos;s independent Medicaid advisory commission — voted 15-2 to recommend that CMS publish a transparent monitoring and evaluation plan for the H.R. 1 community-engagement (work) requirements before the January 1, 2027 implementation, anchored on minimizing administrative burden, timely public state data, and measuring actual employment and health outcomes. The same June 2026 report cycle carries four recommendations on automation in Medicaid prior authorization: every adverse PA determination must be reviewed by a human with relevant clinical expertise (automation alone cannot deny), CMS must extend the same rule to fee-for-service, issue managed-care AI oversight guidance, and require MCOs to disclose AI use to states. For FQHCs juggling 10-20 Medicaid MCO contracts, the human-review recommendation is the federal counterweight to algorithmic denial engines — and the monitoring framework gives state PCAs the yardstick to hold their Medicaid agencies to as work requirements roll out.

Primary source: MACPAC — https://www.macpac.gov/publication/implementing-community-engagement-requirements-in-medicaid/</description>
      <pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/macpac-june-2026-report-work-req-monitoring-ai-prior-auth</guid>
      <category>legislation</category>
      <source url="https://www.macpac.gov/publication/implementing-community-engagement-requirements-in-medicaid/">MACPAC</source>
    </item>
    <item>
      <title>Washington&apos;s 340B protection law survives — and the national map now splits clean: 22 state laws, two circuits upholding, one blocking, DOJ siding with manufacturers</title>
      <link>https://www.fqhctalent.com/intel/wa-340b-law-survives-circuit-split-deepens-june-2026</link>
      <description>On June 9, 2026 a federal judge denied AbbVie, AstraZeneca, Novartis, and PhRMA&apos;s bid to block Washington&apos;s SB 5981, letting the nation&apos;s 22nd state 340B contract-pharmacy protection law take effect June 10 with penalties up to $5,000/day. The ruling sharpens the cleanest circuit split in health law: the 5th Circuit upheld Louisiana&apos;s law (Feb 9) and Mississippi&apos;s in two separate cases (Apr 9), Minnesota&apos;s state appeals court upheld its law (Feb 17) — while the 4th Circuit blocked West Virginia&apos;s as likely federally preempted (Mar 31) and a North Dakota judge struck that state&apos;s law in April. Two more wrinkles tilt the field: the Trump DOJ filed amicus briefs in the Colorado and Rhode Island cases (Feb 2026) backing the manufacturers&apos; preemption theory — a first — and Kansas becomes the only state moving backward, its protections expiring June 30 after the renewal bill died. Multiple law firms now expect Supreme Court review. For multi-state FQHC networks, 340B contract-pharmacy security now varies by federal judicial circuit; the NACHC state-law tracker is the canonical map.

Primary source: Washington State Standard / NACHC State 340B Tracker — https://washingtonstatestandard.com/2026/06/09/was-controversial-new-drug-pricing-law-upheld-amid-legal-challenge/</description>
      <pubDate>Tue, 09 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/wa-340b-law-survives-circuit-split-deepens-june-2026</guid>
      <category>legislation</category>
      <source url="https://washingtonstatestandard.com/2026/06/09/was-controversial-new-drug-pricing-law-upheld-amid-legal-challenge/">Washington State Standard / NACHC State 340B Tracker</source>
    </item>
    <item>
      <title>House Appropriations approves the FY2027 Labor-HHS bill 34-28 — with no Community Health Center Fund extension, the Dec 31 cliff now rides on a bill that doesn&apos;t exist yet</title>
      <link>https://www.fqhctalent.com/intel/fy2027-lhhs-house-committee-no-chc-fund-fix-june-2026</link>
      <description>The House Appropriations Committee approved the FY2027 Labor-HHS-Education bill on June 9, 2026 on a party-line 34-28 vote, funding HHS about 3% (~$5.6B) below FY2026. The structural point for health centers: appropriations only carry the ~$1.9B discretionary slice of Health Center Program funding — the mandatory Community Health Center Fund (~$4.6B/yr, ~70% of federal CHC money) expires December 31, 2026 and requires separate reauthorizing legislation from Energy &amp; Commerce / Senate HELP, where no bill has been introduced. The party-line vote also signals FY2027 appropriations won&apos;t pass by October 1, making another continuing resolution near-certain — a CR holds discretionary funding flat but does nothing for the mandatory cliff. NACHC&apos;s 288-House/57-Senate sign-on letters remain the only vehicle-in-waiting; the realistic path is a year-end package, which means health center boards should plan Q1-2027 cash positions assuming the cliff resolves late, retroactively, or partially. WORKFORCE LINE ITEMS (added 2026-07-20, per an ACU policy update): within that same House bill the National Health Service Corps receives $133.1 million in discretionary funding, a $3.1M / 2.3% increase over FY2026, and HRSA Title VII/VIII workforce programs are held flat at $825.8 million. At a June 17 markup the Senate HELP Committee declined to adopt an amendment increasing NHSC funding, though Title VII/VIII reauthorization remains in play. NHSC loan repayment and scholarships are a core FQHC clinician-recruitment tool, so a 2.3% discretionary bump alongside an unresolved mandatory cliff is the shape of the whole federal picture: the recruiting subsidy inches up while the base funding it recruits into stays unresolved.

Primary source: House Appropriations / CRFB — https://www.crfb.org/blogs/appropriations-watch-fy-2027</description>
      <pubDate>Tue, 09 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/fy2027-lhhs-house-committee-no-chc-fund-fix-june-2026</guid>
      <category>funding</category>
      <source url="https://www.crfb.org/blogs/appropriations-watch-fy-2027">House Appropriations / CRFB</source>
    </item>
    <item>
      <title>NHSC FY2026 raises loan-repayment awards (primary care up to $80K) — but the federal workforce-funding pipeline behind it is on a cliff</title>
      <link>https://www.fqhctalent.com/intel/nhsc-fy2026-awards-federal-workforce-funding-squeeze-june-2026</link>
      <description>The FY2026 National Health Service Corps cycle (applications closed March 31, 2026; awards by Sept 30) raised maximum loan-repayment amounts for eligible clinicians at qualifying sites: the standard Loan Repayment Program lists higher primary-care maximums, plus a Spanish-language-proficiency enhancement; the Rural Community LRP and Students-to-Service tracks also carry larger advertised ceilings. The catch sits upstream: NHSC mandatory funding was extended only through Jan 30, 2026 and now runs on a continuing resolution (~$350M/yr vs. NACHC&apos;s $950M/yr ask), the Community Health Center Fund expires Dec 31, 2026, and the FY2027 President&apos;s Budget proposes zeroing out 14 Title VII/VIII workforce-pipeline programs (HCOP, SDS, AHEC, PCTE, nursing-workforce grants). FQHC recruiters should verify each candidate against the current HRSA track, site status, HPSA score, service schedule, and award rules, while leadership treats the Dec 31 funding cliff as the real workforce risk.

Primary source: HRSA / National Health Service Corps — https://nhsc.hrsa.gov/loan-repayment/nhsc-loan-repayment-program</description>
      <pubDate>Tue, 09 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/nhsc-fy2026-awards-federal-workforce-funding-squeeze-june-2026</guid>
      <category>workforce</category>
      <source url="https://nhsc.hrsa.gov/loan-repayment/nhsc-loan-repayment-program">HRSA / National Health Service Corps</source>
    </item>
    <item>
      <title>FTCA CY2027 redeeming applications due June 26 — miss it and your FQHC has a malpractice-coverage gap</title>
      <link>https://www.fqhctalent.com/intel/ftca-cy2027-redeeming-deadline-june-26-2026</link>
      <description>HRSA Program Assistance Letter 2026-01 sets June 26, 2026 as the deadline for all currently-deemed health centers (and their sub-recipients) to submit CY2027 Federal Tort Claims Act redeeming applications — the annual filing that renews free federal medical-malpractice liability coverage. A lapse forces the center to buy private malpractice insurance to cover the gap for all of 2027. The risk is sharper this year because HRSA&apos;s EHB-to-GrantSolutions system migration is happening in the same window, making the deadline easier to miss. Compliance officers should confirm submission well before June 26.

Primary source: HRSA BPHC (PAL 2026-01) — https://bphc.hrsa.gov/compliance/ftca/application-process</description>
      <pubDate>Tue, 09 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/ftca-cy2027-redeeming-deadline-june-26-2026</guid>
      <category>compliance</category>
      <source url="https://bphc.hrsa.gov/compliance/ftca/application-process">HRSA BPHC (PAL 2026-01)</source>
    </item>
    <item>
      <title>Two Compliance Signals for FQHCs: HRSA&apos;s FY2026 340B Manufacturer-Audit Results Go Live, and OCR&apos;s Ransomware Settlements Preview a Tougher HIPAA Security Rule</title>
      <link>https://www.fqhctalent.com/intel/hrsa-fy26-340b-audit-ocr-risk-analysis-security-rule-preview-2026</link>
      <description>Two federal compliance developments worth a calendar note. First, HRSA published its FY2026 340B Manufacturer Audit Results page (updated May 28, 2026) — the companion to the already-tracked FY2025 cycle (49% adverse findings); results are partially finalized, with corrective-action plans and any sanctions to be posted as HRSA approves them, and the agency advises covered entities not to contact audited manufacturers until CAPs post. FQHCs are the largest class of 340B covered entities, so this is a standing reference to monitor in OPAIS. Second, OCR&apos;s Risk Analysis Initiative has now completed 19 ransomware investigations with six 2026 settlements, and a June 1 Sidley analysis frames the recent settlements as a direct preview of the forthcoming HIPAA Security Rule amendments (which would make annual risk analyses, documented asset inventories, and demonstrated remediation mandatory rather than &apos;addressable&apos;). No FQHC has been named, but FTCA-covered health centers are full HIPAA covered entities — meaning a center that hasn&apos;t completed a documented Security Risk Analysis is accumulating enforcement exposure ahead of a rule change, not just theoretical risk. (Affordable FQHC SRA tooling like Medcurity, added to our tech stack this cycle, exists precisely for this gap.)

Primary source: Sidley Data Matters / HRSA OPA / Nixon Peabody — https://datamatters.sidley.com/2026/06/01/risk-analysis-in-the-crosshairs-four-recent-ransomware-resolutions-preview-the-hipaa-security-rule-amendments/</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/hrsa-fy26-340b-audit-ocr-risk-analysis-security-rule-preview-2026</guid>
      <category>compliance</category>
      <source url="https://datamatters.sidley.com/2026/06/01/risk-analysis-in-the-crosshairs-four-recent-ransomware-resolutions-preview-the-hipaa-security-rule-amendments/">Sidley Data Matters / HRSA OPA / Nixon Peabody</source>
    </item>
    <item>
      <title>CMS Publishes the Medicaid Work-Requirements Rule (CMS-2454-IFC) — 80 Hours/Month, Effective July 31, States Must Implement by Jan 1, 2027</title>
      <link>https://www.fqhctalent.com/intel/cms-medicaid-work-requirements-ifr-published-june-1-2026</link>
      <description>On June 1, 2026 — ahead of its June statutory deadline — CMS issued the interim final rule implementing H.R. 1&apos;s Medicaid &apos;community engagement&apos; (work) requirement. Adults in the expansion group must document 80 hours/month of qualifying activity (employment, work programs, community service, or at-least-half-time education) — or earn roughly $580/month — to keep coverage. The rule is effective July 31, 2026 (the comment period closes the same day), states must begin member outreach by August 31, and full implementation is required by January 1, 2027; it also tightens illness/incapacity exemption eligibility. The Commonwealth Fund estimates 5.6 million community-health-center patients are exposed nationwide. This is the operational floor FQHCs in both California and Texas have been waiting on: it converts the abstract &apos;work requirement&apos; into a concrete navigation problem — every center now has roughly four weeks to finalize its eligibility-redetermination and patient-navigation playbooks before the state outreach window opens. The rule resolves the platform&apos;s two prior &apos;watch&apos; items (it was due; it is now published).

Primary source: CMS (CMS-2454-IFC) — https://www.cms.gov/newsroom/fact-sheets/medicaid-community-engagement-requirement-certain-individuals-interim-final-rule-comment-period-cms</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/cms-medicaid-work-requirements-ifr-published-june-1-2026</guid>
      <category>legislation</category>
      <source url="https://www.cms.gov/newsroom/fact-sheets/medicaid-community-engagement-requirement-certain-individuals-interim-final-rule-comment-period-cms">CMS (CMS-2454-IFC)</source>
    </item>
    <item>
      <title>Eli Lilly Gives ~50 Covered Entities Five Days to Hand Over 340B Claims Data — or Lose Their Discounts</title>
      <link>https://www.fqhctalent.com/intel/lilly-340b-five-day-data-ultimatum-june-1-2026</link>
      <description>On June 1, Eli Lilly escalated its 340B claims-data fight, warning roughly 50 covered entities that they have five days to submit comprehensive claims data or stop receiving 340B price breaks — the first time the manufacturer has issued outright termination threats rather than reminder letters. The demand follows Lilly&apos;s policy announced in January and effective Feb. 1, 2026, which requires claims-level data for all 340B dispenses (including in-house pharmacies, not just contract pharmacies); STAT reports more than 2,300 entities have complied while up to 1,000 larger systems have refused. The first round targets hospital systems, but the policy applies to all covered entities — FQHCs that dispense Lilly products (insulin, oncology, psychiatric drugs) and have not enrolled in the data platform face the same termination risk. With North Dakota&apos;s contract-pharmacy law struck down and other state shields in litigation, this is the manufacturer-side pressure on 340B savings that FQHC pharmacy directors must act on now.

Primary source: STAT News — https://www.statnews.com/pharmalot/2026/06/01/lilly-warns-hospitals-submit-claims-data-or-lose-340b-drug-discounts/</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://www.fqhctalent.com/intel/lilly-340b-five-day-data-ultimatum-june-1-2026</guid>
      <category>compliance</category>
      <source url="https://www.statnews.com/pharmalot/2026/06/01/lilly-warns-hospitals-submit-claims-data-or-lose-340b-drug-discounts/">STAT News</source>
    </item>
  </channel>
</rss>